Cargando…
Multidisciplinary treatment of advanced hepatocellular carcinoma with severe arterioportal shunt: a case report
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer mortality globally. In addition, most patients present in advanced stages with limited curative treatment options. Therefore, multidisciplinary treatment is often warranted. Here, we report a patient with HCC and severe arterioport...
Autores principales: | Luo, Yao-chang, Lu, Hai-lin, Song, Wen-ling, Xuan, Fei-fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278469/ https://www.ncbi.nlm.nih.gov/pubmed/34250825 http://dx.doi.org/10.1177/03000605211024840 |
Ejemplares similares
-
Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma
por: Wu, Huiyong, et al.
Publicado: (2018) -
Polyvinyl Alcohol Embolization Adjuvant to Oily Chemoembolization in Advanced Hepatocellular Carcinoma with Arterioportal Shunts
por: Kim, Yeo Ju, et al.
Publicado: (2007) -
Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With Apatinib
por: Sun, Tao, et al.
Publicado: (2020) -
Transcatheter Arterial Chemoembolization and Chemotherapy plus Sorafenib in a Large Hepatocellular Carcinoma with Arterioportal Shunt
por: Chen, Jun, et al.
Publicado: (2014) -
Sonography of hepatic hemangioma accompanied by arterioportal shunt
por: Choi, Sang Hyun, et al.
Publicado: (2014)